Butterfly Network, Inc. (NYSE:BFLY), a digital health company transforming care through portable, semiconductor-based ultrasound technology and intuitive software, today announced the appointment of Victor Ku as Senior Vice President and Chief Technology Officer (CTO). Victor will join the company in late September and will be responsible for leading Butterfly's global technology strategy, product development, and innovation roadmap.
"Victor's deep expertise in semiconductor-based imaging and his proven ability to scale global product development make him a perfect fit for Butterfly's next phase of growth," said Joseph DeVivo, President and CEO of Butterfly Network. "His leadership will be instrumental as we continue advancing our mission to democratize medical imaging and improve clinical outcomes around the world."
Victor brings more than two decades of leadership experience across regulated, industrial, and high-tech environments. He has led and scaled global engineering organizations across the U.S., Europe, and Asia, delivering advanced imaging systems that integrate embedded IoT, AI-based analytics, and complex sensor technologies.
Most recently, Victor served as Vice President of R&D, Engineering, and PMO at Headwall Photonics, where he led the development of hyperspectral imaging products for applications in remote sensing, machine vision, and precision agriculture. His previous leadership roles include senior positions at Teledyne FLIR and EFI, where he oversaw global teams delivering high-performance, hardware-software integrated platforms in demanding commercial and regulated markets. Victor holds a PhD in Engineering Science and Electrical Engineering from Oxford University and an Executive Certificate in Managing Product Platforms from MIT.
About Butterfly Network
Butterfly Network, Inc. (NYSE:BFLY) is a healthcare company driving a digital revolution in medical imaging with its proprietary Ultrasound-on-Chip™ semiconductor technology and ultrasound software solutions. In 2018, Butterfly launched the world's first handheld, single-probe, whole-body ultrasound system, Butterfly iQ. The iQ+ followed in 2020, and the iQ3 in 2024, each with improved processing power and performance by leveraging Moore's Law. The iQ3 earned Best Medical Technology at the 2024 Prix Galien USA Awards, a prestigious honor and one of the highest accolades in healthcare. Butterfly's innovations have also been recognized by Fierce 50, TIME's Best Inventions and Fast Company's World Changing Ideas, among other achievements.
Butterfly combines advanced hardware, intelligent software, AI, services, and education to drive adoption of affordable, accessible imaging. Clinical publications demonstrate that its handheld ultrasound probes paired with Compass™ enterprise workflow software, can help hospital systems improve care workflows, reduce costs, and enhance provider economics. With a cloud-based solution that enables care anywhere through next-generation mobility, Butterfly aims to democratize healthcare by addressing critical global healthcare challenges. Butterfly devices are commercially available to trained healthcare practitioners in areas including, but not limited to, parts of Africa, Asia, Australia, Europe, the Middle East, North America and South America; to learn more about available countries, visit: https://www.butterflynetwork.com/choose-your-country.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250909846660/en/
Media Contact:
SHIFT Communications
[email protected]
Investors Contact:
Steven Halper
Managing Director, LifeSci Advisors
[email protected]